Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.
Chang A, Akhtar A, Lai L, Orellana-Noia VM, Linderman SL, McCook-Veal AA, Switchenko JM, Saini M, Valanparambil RM, Blum KA, Allen PB, Lechowicz MJ, Romancik JT, Ayers A, Leal A, O'Leary CB, Churnetski MC, Baird K, Kives M, Wrammert J, Nooka AK, Koff JL, Dhodapkar MV, Suthar MS, Cohen JB, Ahmed R. Chang A, et al. Among authors: ahmed r. Cancer Res Commun. 2022 Dec;2(12):1684-1692. doi: 10.1158/2767-9764.crc-22-0471. Cancer Res Commun. 2022. PMID: 36644323 Free PMC article.
COVID-19 and the eye: Systemic and laboratory risk factors for retinopathy and detection of tear film SARS-CoV-2 RNA with a triplex RT-PCR assay.
Shantha JG, Fashina T, Stittleburg V, Randleman C, Ward L, Regueiro M, Krakow D, Linderman SL, Drews-Botsch C, Ahmed R, Waggoner J, Yeh S. Shantha JG, et al. Among authors: ahmed r. PLoS One. 2022 Nov 9;17(11):e0277301. doi: 10.1371/journal.pone.0277301. eCollection 2022. PLoS One. 2022. PMID: 36350841 Free PMC article.
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response.
Patel A, Kumar S, Lai L, Chakravarthy C, Valanparambil R, Reddy ES, Gottimukkala K, Bajpai P, Raju DR, Edara VV, Davis-Gardner ME, Linderman S, Dixit K, Sharma P, Mantus G, Cheedarla N, Verkerke HP, Frank F, Neish AS, Roback JD, Davis CW, Wrammert J, Ahmed R, Suthar MS, Sharma A, Murali-Krishna K, Chandele A, Ortlund EA. Patel A, et al. Among authors: ahmed r. Structure. 2023 Jul 6;31(7):801-811.e5. doi: 10.1016/j.str.2023.04.010. Epub 2023 May 11. Structure. 2023. PMID: 37167972 Free PMC article.
Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron.
Patel A, Kumar S, Lai L, Keen M, Valanparambil R, Chakravarthy C, Laughlin Z, Frank F, Cheedarla N, Verkerke HP, Neish AS, Roback JD, Davis CW, Wrammert J, Sharma A, Ahmed R, Suthar MS, Murali-Krishna K, Chandele A, Ortlund E. Patel A, et al. Among authors: ahmed r. Cell Rep. 2023 Sep 26;42(9):113150. doi: 10.1016/j.celrep.2023.113150. Epub 2023 Sep 13. Cell Rep. 2023. PMID: 37708028 Free PMC article.
Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults.
Joshi D, Nyhoff LE, Zarnitsyna VI, Moreno A, Manning K, Linderman S, Burrell AR, Stephens K, Norwood C, Mantus G, Ahmed R, Anderson EJ, Staat MA, Suthar MS, Wrammert J. Joshi D, et al. Among authors: ahmed r. iScience. 2023 Sep 20;26(10):107967. doi: 10.1016/j.isci.2023.107967. eCollection 2023 Oct 20. iScience. 2023. PMID: 37822504 Free PMC article.
Pembrolizumab and low-dose, single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma: a prospective, single-centre, single-group, open-label, phase 2 pilot trial in the USA.
Khan MK, Nasti TH, Qian JY, Kleber TJ, Switchenko JM, Kaufman JL, Nooka AJ, Dhodapkar MV, Buchwald ZS, Obiekwe D, Lonial S, Ahmed R. Khan MK, et al. Among authors: ahmed r. Lancet Haematol. 2024 Jul;11(7):e510-e520. doi: 10.1016/S2352-3026(24)00105-4. Epub 2024 May 23. Lancet Haematol. 2024. PMID: 38797190 Clinical Trial.
Reversible, tunable epigenetic silencing of TCF1 generates flexibility in the T cell memory decision.
Abadie K, Clark EC, Valanparambil RM, Ukogu O, Yang W, Daza RM, Ng KKH, Fathima J, Wang AL, Lee J, Nasti TH, Bhandoola A, Nourmohammad A, Ahmed R, Shendure J, Cao J, Kueh HY. Abadie K, et al. Among authors: ahmed r. Immunity. 2024 Feb 13;57(2):271-286.e13. doi: 10.1016/j.immuni.2023.12.006. Epub 2024 Jan 31. Immunity. 2024. PMID: 38301652 Free article.
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
Saba NF, Wong SJ, Nasti T, McCook-Veal AA, McDonald MW, Stokes WA, Anderson AM, Ekpenyong A, Rupji M, Abousaud M, Rudra S, Bates JE, Remick JS, Joshi NP, Woody NM, Awan M, Geiger JL, Shreenivas A, Samsa J, Ward MC, Schmitt NC, Patel MR, Higgins KA, Teng Y, Steuer CE, Shin DM, Liu Y, Ahmed R, Koyfman SA. Saba NF, et al. Among authors: ahmed r. JAMA Oncol. 2024 Jul 1;10(7):896-904. doi: 10.1001/jamaoncol.2024.1143. JAMA Oncol. 2024. PMID: 38780927 Clinical Trial.
3,418 results